Total Payments
$20,707
2024 Payments
$1,666
Companies
42
Transactions
1,060
Medicare Patients
3,966
Medicare Billing
$426,372
Payment Breakdown by Category
Food & Beverage$20,471 (98.9%)
Gifts$178.20 (0.9%)
Education$57.77 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,471 | 1,046 | 98.9% |
| Gift | $178.20 | 3 | 0.9% |
| Education | $57.77 | 11 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,973 | 145 | $0 (2023) |
| Lilly USA, LLC | $2,838 | 148 | $0 (2024) |
| Mannkind Corporation | $2,305 | 121 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $2,174 | 111 | $0 (2024) |
| Novo Nordisk Inc | $1,463 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,361 | 65 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $929.45 | 45 | $0 (2024) |
| ABBVIE INC. | $820.63 | 48 | $0 (2024) |
| Abbott Laboratories | $650.91 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $600.79 | 35 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,666 | 77 | Lilly USA, LLC ($323.67) |
| 2023 | $2,241 | 102 | Lilly USA, LLC ($420.70) |
| 2022 | $2,720 | 129 | AstraZeneca Pharmaceuticals LP ($493.23) |
| 2021 | $3,200 | 159 | Lilly USA, LLC ($469.95) |
| 2020 | $2,661 | 136 | AstraZeneca Pharmaceuticals LP ($490.44) |
| 2019 | $2,942 | 164 | AstraZeneca Pharmaceuticals LP ($474.03) |
| 2018 | $2,792 | 136 | AstraZeneca Pharmaceuticals LP ($457.69) |
| 2017 | $2,485 | 157 | AstraZeneca Pharmaceuticals LP ($529.28) |
All Payment Transactions
1,060 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $24.72 | General |
| 11/01/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.01 | General |
| 10/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: DIABETES | ||||||
| 08/14/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/06/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes Care | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: DIABETES MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 920 | 1,492 | $312,899 | $105,955 |
| 2022 | 12 | 1,054 | 1,679 | $284,279 | $117,963 |
| 2021 | 14 | 1,036 | 1,586 | $242,999 | $112,021 |
| 2020 | 9 | 956 | 1,464 | $225,631 | $90,433 |
Total Patients
3,966
Total Services
6,221
Medicare Billing
$426,372
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 465 | $127,875 | $44,851 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 125 | 125 | $50,000 | $18,009 | 36.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 64 | $27,520 | $9,651 | 35.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 90 | $20,250 | $9,320 | 46.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 72 | 74 | $20,720 | $6,756 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $15,375 | $5,505 | 35.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 78 | $23,400 | $5,370 | 22.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 25 | 62 | $8,184 | $1,773 | 21.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,900 | $1,485 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 20 | $4,000 | $1,475 | 36.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 187 | 415 | $8,300 | $1,332 | 16.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 45 | $3,375 | $428.40 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 286 | 462 | $100,500 | $43,319 | 43.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 95 | 115 | $38,660 | $19,609 | 50.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 126 | 126 | $35,100 | $17,942 | 51.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 133 | $28,250 | $11,620 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $17,625 | $7,253 | 41.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 76 | 78 | $21,840 | $6,832 | 31.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 73 | $12,800 | $4,455 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 41 | $6,550 | $2,957 | 45.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 25 | 57 | $7,524 | $1,610 | 21.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 193 | 444 | $8,880 | $1,438 | 16.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 66 | 74 | $5,550 | $710.57 | 12.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 20 | $1,000 | $216.90 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 297 | 501 | $100,200 | $49,664 | 49.6% |
About Dr. Hernan Baquerizo, M.D
Dr. Hernan Baquerizo, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053378893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hernan Baquerizo, M.D has received a total of $20,707 in payments from pharmaceutical and medical device companies, with $1,666 received in 2024. These payments were reported across 1,060 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($20,471).
As a Medicare-enrolled provider, Baquerizo has provided services to 3,966 Medicare beneficiaries, totaling 6,221 services with total Medicare billing of $426,372. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Miami, FL
- Active Since 04/26/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053378893
Products in Payments
- AFREZZA (Drug) $2,305
- JARDIANCE (Drug) $1,645
- FARXIGA (Drug) $1,588
- UNITHROID (Drug) $1,081
- BYDUREON (Drug) $860.18
- Ozempic (Drug) $855.68
- BAQSIMI (Drug) $669.07
- SOLIQUA 100/33 (Biological) $648.71
- JANUVIA (Drug) $544.48
- TOUJEO (Biological) $540.09
- HUMULIN (Drug) $519.37
- TRULICITY (Drug) $497.81
- MOUNJARO (Drug) $432.31
- TOUJEO (Drug) $429.65
- Rybelsus (Drug) $387.69
- INVOKANA (Drug) $381.71
- SYNTHROID (Drug) $351.23
- TRADJENTA (Drug) $307.72
- Omnipod (Device) $282.20
- GVOKE PFS (Drug) $274.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Miami
Dr. Eugenio Angueira-Serrano, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $634,312
Endocrinology, Diabetes & Metabolism $634,312
Camillo Ricordi, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $66,313
Endocrinology, Diabetes & Metabolism $66,313
Dr. Neil Goodman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $49,371
Endocrinology, Diabetes & Metabolism $49,371
Sudah Shaheb
Endocrinology, Diabetes & Metabolism — Payments: $17,262
Endocrinology, Diabetes & Metabolism $17,262
Dr. Damon Helms, D.o, D.O
Endocrinology, Diabetes & Metabolism — Payments: $15,794
Endocrinology, Diabetes & Metabolism $15,794
Dr. Barbara Muina, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $14,069
Endocrinology, Diabetes & Metabolism $14,069